Anesthetic Considerations for the HIV+ Patient
description
Transcript of Anesthetic Considerations for the HIV+ Patient
![Page 1: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/1.jpg)
Anesthetic Considerations
for the HIV+ Patient
Veronica Y. Amos PhD CRNA
October 2014
![Page 2: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/2.jpg)
Prevalence
In 2011, an estimated 1.1 million persons in the U.S. were living with HIV infection
1 in 6 (15.8%) are unaware they are HIV positive
![Page 3: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/3.jpg)
Incidence
Centers for Disease Control (CDC) estimated that approximately 50,000 people are newly infected with HIV
![Page 4: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/4.jpg)
![Page 5: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/5.jpg)
HIV versus AIDS
HIV: Human Immunodeficiency Virus - a retrovirus that specifically infects several kinds of cells in the human body, the most important is the CD4 T-Lymphocyte
![Page 6: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/6.jpg)
HIV versus AIDS
AIDS: Acquired Immunodeficiency Syndrome - When an individual’s CD4 T-Lymphocyte cell count has fallen below 200, and/or the individual has developed some specific and opportune infections.
![Page 7: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/7.jpg)
HIV Targets T Cells
T cells act as the host that the HIV virus needs in order to replicate
![Page 8: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/8.jpg)
CD4 Receptor Site
CD4 is a protein on the surface of the T cell. HIV’s gp120 antigen is a mirror image of the CD4 protein.
![Page 9: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/9.jpg)
![Page 10: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/10.jpg)
HIV Takes Control
of T Cells
Viral RNA needs to become DNA in order to start the replication process. Reverse transcriptase allows the RNA to borrow material from the cell and to "write backwards" a chain of viral DNA.
![Page 11: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/11.jpg)
CD4 Values
Normal: 600 -1200 cells per cubic mm of blood
Meds not needed: 600-350
Increased risk: 350-200 (meds may be started)
Risk for opportunistic infections: less than 200
![Page 12: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/12.jpg)
Viral Load
This test detects and/or measures the amount (viral load) of RNA of the HIV in the blood
![Page 13: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/13.jpg)
Viral Load
Untreated and uncontrolled HIV viral loads can range as high as one million or more copies/mL. A low viral load is usually between 40 to 200 copies/mL, depending on the type of test used.
![Page 14: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/14.jpg)
Viral Load
A viral load result that reads “undetectable” does not mean that one is cured.
![Page 15: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/15.jpg)
![Page 16: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/16.jpg)
![Page 17: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/17.jpg)
Adverse Drug Effects from Antiretroviral Drugs (ARVs)
1. Mitochondrial dysfunction
2. Metabolic abnormalities
3. Bone marrow suppression
4. Allergic reactions
![Page 18: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/18.jpg)
Interaction of ARVs with Other
DrugsPropofol and NRTIs may both potentially promote mitochondrial toxicity and lactic acidosis and it may be best to avoid propofol “infusions” in patients receiving ARVs
![Page 19: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/19.jpg)
Pharmacokinetic Interactions
Primarily due to liver enzyme induction or inhibition, particularly the CYP450 3A4 enzyme
PIs and NNRTIs are the most commonly implicated group of ARVs in drug interactions. Enzyme induction or inhibition can affect the action of several classes of anesthetic drugs
![Page 20: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/20.jpg)
Opioids
The effects of fentanyl may be enhanced by ritonavir (protease inhibitor) due to both liver enzyme inhibition and induction
Enzyme inhibition reduces fentanyl clearance and enzyme induction increases metabolism to active metabolites such as normeperidine
![Page 21: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/21.jpg)
Benzodiazepines
Saquiniar (PI) can inhibit midazolam’s metabolism
Combination of PI and NNRTIs – excessive sedation
![Page 22: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/22.jpg)
Other DrugsCalcium Channel Blockers may have enhanced hypotensive effects due to enzyme inhibition
Local anesthetics such as lidocaine may have increased plasma levels due to enzyme inhibition
Neuromuscular blocker effects may be prolonged, even from a single dose of vecuronium
![Page 23: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/23.jpg)
Other Drugs
Proton Pump Inhibitors, and to a lesser extent antacids and H2 blockers, may adversely affect the absorption of the PI atazanavir
PIs impair the metabolism of the cardiac drugs amiodarone and quinidine
![Page 24: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/24.jpg)
Preferable
Etomidate, atracurium, remifentanil and desflurane are not dependent on CYP450 hepatic metabolism, and therefore, may be preferable drugs
![Page 25: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/25.jpg)
Blood Transfusions
There is evidence that allogenic blood transfusion in the HIV infected patient can lead to transfusion-related immunomodulation (TRIM) and can result in an increase in HIV viral load
![Page 26: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/26.jpg)
Pain
Pain is common in advanced HIV disease and can be very difficult to treat. The etiology of this pain can be multi-factorial, including opportunistic infections such as herpes simples, peripheral neuropathy and drug-related pain
![Page 27: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/27.jpg)
Organ Involvement
Organ involvement in HIV infection may be a direct consequence of HIV infection because of an opportunistic infection or neoplasm, or related to other causes such as side effects of the medications
![Page 28: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/28.jpg)
Respiratory
Prevalence of underlying pulmonary disease is increased due to the increased risk for bacterial pneumonia and the high prevalence of smoking
![Page 29: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/29.jpg)
Respiratory
Both upper and lower airway may be involved with HIV infection:
- Bronchitis, sinusitis, pneumonia (PCP)
- TB, myobacteria and fungal infections
- Airway obstruction (Kaposi’s sarcoma)
![Page 30: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/30.jpg)
Risks/Recommendations
Risk for postoperative pneumonia is increased
Carefully evaluate for respiratory complications in the peri-operative period: HIV+ patients with active PCP or a history of PCP are at increased risk for a spontaneous pneumothorax
![Page 31: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/31.jpg)
Cardiovascular
Increased prevalence of CAD from metabolic dysfunction due to HIV infection and/or ART
QT prolongation or other cardiac abnormalities may occur in advanced HIV and/or ART (methadone, anti-arrhythmics, PI, antipsychotics)
![Page 32: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/32.jpg)
Cardiovascular
- Dilated cardiomyopathy
- Pericardial effusions
- Endocarditis and valvular lesions
- Acute coronary syndrome
- Vasculitis
- Pulmonary hypertension
![Page 33: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/33.jpg)
Recommendations
Assess for CAD preoperatively
Perform a careful review of preoperative ECG results
![Page 34: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/34.jpg)
Gastrointestinal - Difficulty or pain on swallowing
- Increased gastric emptying times
- Bleeding tendency on airway instrumentation/NGT placement
- Diarrhea with associated electrolyte dysfunction & dehydration
- Hepatobiliary impairment
- Pancreatitis
![Page 35: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/35.jpg)
Hepatic
Increased prevalence of hepatic dysfunction from ART or from preexisting liver disease
![Page 36: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/36.jpg)
Risks/Recommendations
Co-infection with HBV or HCV may predispose to increased bleeding due to coagulopathy or thrombocytopenia
Assess preoperatively and dose anesthetics, antibiotics, and other medications accordingly
![Page 37: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/37.jpg)
RenalIncreased prevalence of renal dysfunction from HIV-associated nephropathy
- Acute and chronic disease
- Drug-induced nephrotoxicity, HTN, & diabetes
- HIV-associated nephropathy
![Page 38: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/38.jpg)
Recommendations
Assess for renal dysfunction preoperatively due to possible impact on dosing, selection of anesthetics, and peri-operative antibiotics
![Page 39: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/39.jpg)
Neurological
- Neurocognitive impairment
- Encephalopathy
- Autonomic neuropathy
- Seizures
![Page 40: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/40.jpg)
Endocrine & Metabolic
- Lipodystrophy (truncal obesity, buffalo hump)
- Raised plasma triglycerides, cholesterol, glucose
- Disorders of the hypothalamic-pituitary-adrenal axis (Cushings/Addisons)
- Hyponatremia due to syndrome of inappropriate antidiuretic hormone or adrenal failure
- Hypo/hyperthyroidism
- Lactic acidosis
![Page 41: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/41.jpg)
Hematological
- Anemia
- Neutropenia with severe immunosuppession
- Thrombocytopenia
- Persistent generalized lymphadenopathy
- Hematological malignancies
- Coagulation abnormalities
![Page 42: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/42.jpg)
Recommendations
Consult with hematologist prior to procedure when platelet count approaches 50,000
![Page 43: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/43.jpg)
MRSA
Community-acquired is more common in MSM than in the general population
![Page 44: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/44.jpg)
Recommendations
Good history of previous MRSA infections
Use vancomycin instead of cefazolin for prophylaxis with a positive history of MRSA
![Page 45: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/45.jpg)
HIV Infected Parturient
The advances in HIV treatment have also brought down the rate of mother-to-child HIV transmission significantly. If the mother takes appropriate medical precautions, including taking HIV drugs, the rate of transmission can be reduced from about 25 percent to below 2 percent. In addition, studies have shown that being pregnant will not make HIV progress faster in the mother
![Page 46: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/46.jpg)
HIV Infected Parturient
HIV infection does not contraindicate the administration of neuraxial anesthesia analgesia during labor and/or for a cesarean section). HIV is a neurotropic virus, and the CNS is infected early in the course of the disease.
![Page 47: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/47.jpg)
HIV Infected Parturient
Vertical transmission is increased when CD4 (T-cell counts) decrease below 400 mL and viral load increases over 1000 copies/mL
Elective C-Sections combined with antiretroviral therapy has reduced vertical transmission to <5%
![Page 48: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/48.jpg)
HIV Infected Parturient
Risk factors for vertical transmission include prolonged preterm rupture of membranes (>4 hrs), chorioamnionitis, presence of STD, lack of maternal antiviral therapy, and obstetrical invasive procedures such as cervical cerclage and amniocentesis
![Page 49: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/49.jpg)
Key Points to Remember
If the HIV patient is on a cocktail and they are told to hold a HIV med before surgery….they need to discontinue them all and restart them all together
![Page 50: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/50.jpg)
Key Points to Remember
Occasionally with surgical intervention there may be a temporary or transient increase, also called a blip, in viral load. In people whose viral load is less than 50 copies, blips are a frequent occurrence and is not associated with a sustained increase in viral load.
![Page 51: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/51.jpg)
Risk for Occupational Transmission of HIV
Percutaneous exposure – approx 0.3%
Mucous membrane exposure – approx 0.09%
![Page 52: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/52.jpg)
Occupational Exposure to HIV
Places you at risk:
Percutaneous injury (needlestick or cut with a sharp object)
Contact of mucous membrane or non-intact skin
Blood, tissue, or other body fluids (cerebrospinal, synovial, pleural, peritoneal, pericardial, and amniotic fluid)
![Page 53: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/53.jpg)
Remember
Just because a source patient has an undetectable serum viral load – it does not eliminate the possibility of HIV transmission or the need for post-exposure prophylaxis (PEP ) & follow-up testing
![Page 54: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/54.jpg)
Recommendations
PEP is recommended
Start PEP medication regimens as soon as possible (within 72 hrs) after occupational exposure & continue for a 4-week duration
PEP should contain 3 (or more) ART drugs that have the fewest side-effects & are best tolerated
![Page 55: Anesthetic Considerations for the HIV+ Patient](https://reader037.fdocuments.in/reader037/viewer/2022102606/56812fc2550346895d9542c2/html5/thumbnails/55.jpg)
Follow-up TestingHIV testing at baseline, 6 weeks, 12 weeks, 6 months post-exposure
Complete blood count, renal and hepatic function tests at baseline and 2 weeks
HIV test results should preferable be given to the exposed healthcare provider at face to face appointments